<SEC-DOCUMENT>0000876661-18-001081-index.html : 20181009 <SEC-HEADER>0000876661-18-001081.hdr.sgml : 20181009 <ACCEPTANCE-DATETIME>20181009143016 ACCESSION NUMBER: 0000876661-18-001081 CONFORMED SUBMISSION TYPE: 25-NSE PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20181009 DATE AS OF CHANGE: 20181009 EFFECTIVENESS DATE: 20181009 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 25-NSE SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 181113357 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NYSE AMERICAN LLC CENTRAL INDEX KEY: 0001143313 IRS NUMBER: 522127241 FILING VALUES: FORM TYPE: 25-NSE BUSINESS ADDRESS: STREET 1: 11 Wall Street CITY: New York STATE: NY ZIP: 10005 BUSINESS PHONE: 212-656-5414 MAIL ADDRESS: STREET 1: 11 Wall Street CITY: New York STATE: NY ZIP: 10005 FORMER COMPANY: FORMER CONFORMED NAME: NYSE MKT LLC DATE OF NAME CHANGE: 20120514 FORMER COMPANY: FORMER CONFORMED NAME: NYSE Amex DATE OF NAME CHANGE: 20090402 FORMER COMPANY: FORMER CONFORMED NAME: NYSE Alternext US LLC DATE OF NAME CHANGE: 20081009 </SEC-HEADER> <DOCUMENT> <TYPE>25-NSE <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.25 <SEQUENCE>2 <FILENAME>ruleprovisionnotice.htm <TEXT> Document 2 - file: ruleprovisionnotice.htm
</DOCUMENT> </SEC-DOCUMENT>